Oblimersen in Treating Patients With Merkel Cell Carcinoma

Clinical trial NCT00079131 · COMPLETED

Trial details

NCT number: NCT00079131
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Neuroendocrine Carcinoma of the Skin Stage I Neuroendocrine Carcinoma of the Skin Stage II Neuroendocrine Carcinoma of the Skin Stage III Neuroendocrine Carcinoma of the Skin Stage IV Neuroendocrine Carcinoma of the Skin

Start date: 2004-01-01
Primary completion: 2007-01-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.